← Tenders
Romania – Medical imaging services – Endovascular angiographic diagnostic and treatment services
Spitalul Judetean de Urgenta Tulcea (Tulcea County Emergency Hospital) · Romania
Original notice title
Romania – Medical imaging services – Servicii de diagnostic si tratament endovascular angiografic
Deadline
No deadline stated
Archived
Estimated value
Not disclosed
Market relevance
92
Company fit
Not assessed
Summary
Tulcea County Emergency Hospital in Romania is procuring endovascular angiographic diagnostic and treatment services. This is a direct fit for medical imaging device suppliers, particularly those offering angiography systems, imaging monitors, and related capital equipment used in interventional radiology.
Preliminary summary.
Requirements
A free account includes requirements on 2 tenders a month.
An account lets you read the requirements
Create a free accountTender Evaluation
Compare the tender requirements with your company evidence to identify matches, gaps and partner needs.
This tender is archived.
This reads the tender and scores your fit. It needs an account, your company information, and a plan that includes evaluations.
Add your company information to assess your fit
Create an accountProposal brief
Build a starting brief from your evaluation, including evidence, unresolved requirements and roles a partner needs to cover.
This tender is archived.
It lists what you can answer, what stays open, and what a partner covers. It needs an evaluation first, and a plan that includes proposal briefs.
The brief is written after an evaluation
Create an accountTender Documents 7
Notices 7
Contract notice — TED 706037-2024PDF ↓Contract award notice — TED 45912-2025 RevisedPDF ↓Contract award notice — TED 271214-2025 RevisedPDF ↓Contract award notice — TED 583142-2025 RevisedPDF ↓Contract award notice — TED 5423-2026 RevisedPDF ↓Contract award notice — TED 219939-2026 RevisedPDF ↓Contract award notice — TED 437535-2026 RevisedPDF ↓Timeline 7
This tender is archived.
Source
Comments 0
Log in to comment.
No comments yet — start the conversation.